LSIPR, Gowling WLG team up for biologics survey
22-06-2021
LSIPR webinar: HGF delves into personalised healthcare patents
13-09-2018
LSIPR Webinar: Greater scrutiny for late-filed EPO documents, says HGF
22-03-2018
Dmitrii_Guzhanin / iStockphoto.com
The case of Actavis v Eli Lilly introduced “a real change in the law” and the way in which it addresses the doctrine of equivalence, according to Douglas Drysdale, partner at HGF in Glasgow, UK.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Webinar, Douglas Drysdale, HGF, Actavis v Lilly, Improver, patent infringement test, patent claim scope, invention, doctrine of equivalence, Lord Neuberger
